|Last Price||Today's Change||52-Week Range||Trading Volume|
|70.37||-0.77 (-1.08%)||65.94 - 77.31||2.9 million|
Market data as of 4:00PM 04/27/15. Quotes are delayed by at least 15 min.
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
04/27/2015 7:00 AM ET
Baxter Reports First Quarter Financial Results That Exceed Guidance
04/23/2015 7:00 AM ET